Mental telehealth startups such as Cerebral and Done Health are coming under increased scrutiny for the way they prescribe drugs with a high potential for abuse like Adderall.
Driving the news: Cerebral announced quality and safety changes on Wednesday, telling clinicians it will stop prescribing Adderall and other controlled substances to treat attention deficit hyperactivity disorder for new patients.